Skip to main content
. 2012 Sep 25;47(3):213–218. doi: 10.5045/kjh.2012.47.3.213

Fig. 4.

Fig. 4

Overall survival of patients at stage IV of the disease, treated with rituximab (Median overall survival: not reached, P=0.53).